Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoru Morimoto

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Cell Stem Cell|February 5, 2022
iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disordersHideyuki Okano, Satoru Morimoto
Expert Opinion on Drug Discovery|June 24, 2026
Are patient-derived models of amyotrophic lateral sclerosis a game changer for novel drug discovery?Satoru Morimoto, Hideyuki Okano
Movement Disorders : Official Journal of the Movement Disorder Society|October 31, 2008
Increased oxidative stress in patients with amyotrophic lateral sclerosis/Parkinsonism-dementia complex in the Kii peninsula, JapanSatoru Morimoto, Shigeki Kuzuhara, Yasumasa Kokubo
Neural Regeneration Research|October 31, 2025
Advancements in differentiation of induced pluripotent stem cells into specialized neuronal subtypesSelena Setsu, Hideyuki Okano, Satoru Morimoto
Brain and Nerve = Shinkei Kenkyu No Shinpo|September 12, 2019
[Ropinirole Hydrochloride, a Candidate Drug for ALS Treatment]Shinichi Takahashi, Satoru Morimoto, Hideyuki Okano
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 14, 2026
Early anti-C5 therapy in NMOSD: rationale and clinical evidenceHaruka Kido, Satoru Morimoto, Mikiaki Matsuoka
Japanese Journal of Radiology|May 18, 2026
Human iPSC‑based translational and reverse translational research for neurodegenerative diseases: emphasis on ALS and key advancesSatoru Morimoto, Shinichi Takahashi, Hideyuki Okano
Regenerative Therapy|June 26, 2026
Therapeutic frontiers in ALS: iPSC-based drug discovery, cell therapy, and gene therapy-Advances through 2026Satoru Morimoto, Chris Kato, Shinichi Takahashi, et al.
Biochimica Et Biophysica Acta. General Subjects|February 15, 2025
The roles of intrinsically disordered proteins in neurodegenerationKagistia Hana Utami, Satoru Morimoto, Yasue Mitsukura, et al.
Brain and Nerve = Shinkei Kenkyu No Shinpo|November 14, 2019
[Ropinirole Hydrochloride for ALS]Shinichi Takahashi, Satoru Morimoto, Komei Fukushima, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Cell Stem Cell|February 5, 2022
iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disordersHideyuki Okano, Satoru Morimoto
Expert Opinion on Drug Discovery|June 24, 2026
Are patient-derived models of amyotrophic lateral sclerosis a game changer for novel drug discovery?Satoru Morimoto, Hideyuki Okano
Movement Disorders : Official Journal of the Movement Disorder Society|October 31, 2008
Increased oxidative stress in patients with amyotrophic lateral sclerosis/Parkinsonism-dementia complex in the Kii peninsula, JapanSatoru Morimoto, Shigeki Kuzuhara, Yasumasa Kokubo
Neural Regeneration Research|October 31, 2025
Advancements in differentiation of induced pluripotent stem cells into specialized neuronal subtypesSelena Setsu, Hideyuki Okano, Satoru Morimoto
Brain and Nerve = Shinkei Kenkyu No Shinpo|September 12, 2019
[Ropinirole Hydrochloride, a Candidate Drug for ALS Treatment]Shinichi Takahashi, Satoru Morimoto, Hideyuki Okano
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 14, 2026
Early anti-C5 therapy in NMOSD: rationale and clinical evidenceHaruka Kido, Satoru Morimoto, Mikiaki Matsuoka
Japanese Journal of Radiology|May 18, 2026
Human iPSC‑based translational and reverse translational research for neurodegenerative diseases: emphasis on ALS and key advancesSatoru Morimoto, Shinichi Takahashi, Hideyuki Okano
Regenerative Therapy|June 26, 2026
Therapeutic frontiers in ALS: iPSC-based drug discovery, cell therapy, and gene therapy-Advances through 2026Satoru Morimoto, Chris Kato, Shinichi Takahashi, et al.
Biochimica Et Biophysica Acta. General Subjects|February 15, 2025
The roles of intrinsically disordered proteins in neurodegenerationKagistia Hana Utami, Satoru Morimoto, Yasue Mitsukura, et al.
Brain and Nerve = Shinkei Kenkyu No Shinpo|November 14, 2019
[Ropinirole Hydrochloride for ALS]Shinichi Takahashi, Satoru Morimoto, Komei Fukushima, et al.
Pageof 9